• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Highly sensitive method to detect potential cancer biomarker

Bioengineer by Bioengineer
January 31, 2019
in Cancer
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

New platform created using molecular imprinting technology

IMAGE

Credit: Kobe University


Exosomes regulate intercellular communication in cancers, and are drawing attention as a potential cancer biomarker. A Japanese research group has developed a highly sensitive method for detecting these exosomes that could potentially contribute to early detection of cancer.

The research group was focused around faculty in the Kobe University Medical Device Fabrication Engineering Center, led by Professor Toshifumi Takeuchi (Kobe University Graduate School of Engineering) and Professor Ryohei Sasaki (Kobe University Hospital), in collaboration with Kazuyuki Hamada (System Instruments Co., Ltd.). The findings were published on January 3 in Angewandte Chemie International Edition, and featured on the inner cover of the journal.

Exosomes are membrane vesicles consisting of lipid bilayer that measure only about 100 nanometers and are discharged from various cells. Exosomes secreted from cancer cells are closely linked to cancer migration, invasion, and metastasis. By examining these cancer-secreted exosomes, we may be able to develop a new method for early detection of cancer.

Current exosome analysis methods involve complicated and time-consuming procedures, including a combination of ultracentrifugation and affinity separation. If we could differentiate cancer-secreted exosomes from other exosomes in body fluids without complicated pretreatments, this would enable a simple test for early detection of cancer.

Using molecular imprinting technology (Figure 1) [1], the team prepared an artificial polymer film of about 30 nanometers, possessing cavities the size of an exosome on top of the glass substrate (an exosome-binding cavity). Then, using their own post-imprinting technology [2], the researchers selectively introduced antibodies that can recognize membrane proteins on the surface of exosomes, and fluorescent molecules that can report exosome binding information. This resulted in an exosome-sensing chip (Figure 2), a groundbreaking, highly-sensitive fluorescence detection chip combining antibodies and artificial materials. It recognizes the membrane proteins on exosomes, captures the exosomes, and reports the information via changes in fluorescence.

To simplify exosome analysis using this fluorescence-based sensing platform, the team collaborated with System Instruments Co., Ltd. to create a device that automatizes the whole analysis process (Figure 3). This instrument is a highly sensitive CMOS camera-mounted fluorescence microscope equipped with a 3D robot arm. With a custom-made flat-type pipette tip inserted with the exosome sensing substrate, it can automatically carry out suction, discharge, fluorescence detection and substrate cleaning of the samples. Using this equipment, with no pretreatment and within 10 minutes, the team achieved unprecedented high-sensitivity detection of 6 picograms per milliliter. This technology enables us to detect about 150 exosomes in 10 microliters, a level of sensitivity that far surpasses previously reported measuring techniques.

The device was created with the support of the Foundation for Biomedical Research and Innovation at Kobe (President: Nobel Prize Laureate Tasuku Honjo).

For early detection of cancer, we need pre-checks before the disease takes hold, but currently the complexity of these checks means that only a small proportion of people are screened. The instrument developed in this study makes it easier to analyze the exosomes in bodily fluids. “Going forward, we will collect clinical samples on a large scale and carry out exosome analysis,” comments Professor Takeuchi. “If it can be verified that analyzing cancer-secreted exosomes are helpful in cancer screenings, this will contribute to increasing the number of screenings. It can also be applied to cancer tests, treatment effectiveness, predictions of cancer transferal, and post-treatment prognoses.”

###

[1] T. Takeuchi, T. Hayashi, S. Ichikawa, A. Kaji, M. Masui, H. Matsumoto, R. Sasao, Chromatography 2016, 37, 43-64 (Focusing Review, Open access).

[2] T. Takeuchi, H. Sunayama, Chem. Commun. 2018, 54, 6243-6251 (Feature Article).

Media Contact
Eleanor Wyllie
[email protected]

Original Source

http://www.kobe-u.ac.jp/research_at_kobe_en/NEWS/news/2019_01_31_01.html

Related Journal Article

http://dx.doi.org/10.1002/anie.201811142

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologycancerCell BiologyDiagnosticsHealth Care Systems/ServicesMaterialsMedicine/HealthNanotechnology/MicromachinesPolymer Chemistry
Share12Tweet8Share2ShareShareShare2

Related Posts

AI Model Predicts Outcomes in Rare Cervical Cancer

November 24, 2025

Single-Cell Multi-Omics Uncover Cholangiocarcinoma Drivers

November 24, 2025

MIR4435-2HG Drives Early Metastasis, Poor Prognosis

November 24, 2025

Tumor Metabolic Diversity Predicts Lymphoma Outcomes

November 24, 2025
Please login to join discussion

POPULAR NEWS

  • New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    New Research Unveils the Pathway for CEOs to Achieve Social Media Stardom

    202 shares
    Share 81 Tweet 51
  • Scientists Uncover Chameleon’s Telephone-Cord-Like Optic Nerves, A Feature Missed by Aristotle and Newton

    119 shares
    Share 48 Tweet 30
  • Neurological Impacts of COVID and MIS-C in Children

    93 shares
    Share 37 Tweet 23
  • Scientists Create Fast, Scalable In Planta Directed Evolution Platform

    98 shares
    Share 39 Tweet 25

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Revolutionizing Problem Formulation with Feedback-Integrated Prompts

Fuzzy Logic’s Role in Managing COVID-19 Outbreaks

Enhancing Metaphor Comprehension in Kids with Autism

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.